D
DaVita Clinical Research | El Paso, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RBT-9
Bardoxolone Methyl
BION-1301
NNC0519-0130
sodium chloride
BI 685509
Parent organization
This site is a part of DaVita Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
Locations recently updated
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney funct...
Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Semaglutide
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active Lupus Nephritis (LN).
Begins enrollment in 6 months
Lupus Nephritis
Drug: Standard-of-care treatment
Drug: Nipocalimab
Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy
Enrolling
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: BION-1301
Trial sponsors
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems